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TRPVTransient receptor potential channel vanilloid type 6 (TRPV6) is a non-selective cation channel with high
permeability for Ca2+ ions. So far, the role of TRPV6 in pancreatic beta cells is unknown. In the present study,
we characterized the role of TRPV6 in controlling calcium signaling, cell proliferation as well as insulin
expression, and secretion in experimental INS-1E beta cell model. TRPV6 protein production was downregulated
using siRNA by approx. 70%, as detected by Western blot. Intracellular free Ca2+ ([Ca2+]i) was measured by
ﬂuorescence Ca2+ imaging using fura-2. Calcineurin/NFAT signaling was analyzed using a NFAT reporter assay
as well as a calcineurin activity assay. TRPV6 downregulation resulted in impaired cellular calcium inﬂux. Its
downregulation also reduced cell proliferation and decreased insulin mRNA expression. These changes were
companied by the inhibition of the calcineurin/NFAT signaling. In contrast, insulin exocytosis was not affected
by TRPV6 downregulation. In conclusion, this study demonstrates for the ﬁrst time the expression of TRPV6
in INS-1E cells and rat pancreatic beta cells and describes its role in modulating calcium signaling, beta cell
proliferation and insulin mRNA expression. In contrast, TRPV6 fails to inﬂuence insulin secretion.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Calcium signaling is essential to regulate a variety of biological
processes of the pancreatic beta cells. Calcium inﬂux triggers insulin
secretion [1] and modulates beta cell proliferation as well as apoptosis
[2]. Notably, impaired calcium homeostasis in beta cells plays a critical
role in the pathophysiology of type 1 and type 2 diabetes [3,4].
Previous studies indicated that pancreatic beta cells or experimental
beta cell lines express severalmembers of a large family of non-selective
cation entry channels, such as the transient receptor potential vanilloidk4, cyclin-dependent kinase 4;
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owski).(TRPV) channel 2 and 4 [5–7]. TRPV channels are composed of six
membrane-spanning channels (TRPV1–6) which regulate ion inﬂux in
response to thermal, hormonal, pharmacological and osmotic signals [8].
TRPV1 was shown to inﬂuence insulin sensitivity in animals as well
as insulin exocytosis in INS-1E cells, but not in primary beta cells [9–11].
TRPV2 and TRPV4 modulate growth, death as well as insulin exocytosis
in pancreatic beta cells as well as in experimental beta cell lines [5–7,9].
TRPV6 has the highest permeability for calcium ions among all
known TRPVs [12]. Although TRPV6 mRNA is expressed in the exocrine
as well as in the endocrine pancreas [13–15], the function of this
channel in pancreatic beta cells is still unknown. In the present study,
we therefore investigated the role of TRPV6 channel in controlling
calcium homeostasis, cell proliferation as well as insulin expression,
and secretion using a well-established experimental INS-1E rat beta
cell model obtained from INS-1 cell line [16]. This cell line was used
by numerous laboratories to characterize voltage-operated Ca2+
channels as well as other TRP channels in the past [17–21]. Our study
shows that TRPV6 is expressed in INS-1E beta cell line and rat pancreatic
islets. TRPV6 controls calcium homeostasis and stimulates cell
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insulin secretion.
2. Materials and methods
2.1. Materials
Media and supplements for cell culture were purchased from
Biochrom AG (Berlin, Germany). Unless otherwise indicated, all other
reagents were from Sigma Aldrich (Deisenhofen, Germany). Rabbit
anti-TRPV6 antibody and TRPV6 blocking peptide was from Alomon
Labs (Jerusalem, Israel). Mouse anti-β-actin antibody was from Sigma
Aldrich. Guinea Pig anti-insulin antibody was from Dako (Santa Clara,
CA, USA). Rabbit antibodies against phosphorylated ERK1/2, total
ERK1/2 and secondary HRP-linked anti-rabbit and anti-mouse antibod-
ies were from Cell Signaling Technology (Danvers, MA, USA). Secondary
ant-rabbit and anti-Guinea Pig Cy3 and Alexa Fluor® 488 conjugated
antibodies used for immunoﬂuorescence were from Life Technologies
(Carlsbad, CA, USA).
2.2. Cell culture
The experimental model of beta cells (rat insulinoma INS-1E cell
line)was kindly provided byDr. PierreMaechler (Médical Universitaire,
Genève, Switzerland). Cells were cultured as previously published [6].
In brief, RPMImediumwasused supplementedwith 10% FCS, 2mMglu-
tamine, 1 mM sodium pyruvate, 10 mM HEPES buffer and 50 μM beta-
mercaptoethanol at 37 °C in a humidiﬁed atmosphere (5% CO2, 95% O2).
2.3. siRNA transfection
ON-TARGETplus SMARTpool of four individual TRPV6 siRNAs or
non-targeting (nt) siRNA were obtained from Thermo Scientiﬁc
Dharmacon (Waltham, MA, USA). In brief, fast-forward transfection ei-
ther with 30 nM TRPV6 siRNA or 30 nM nt siRNA was performed using
HiPerfect reagent (Qiagen, Hilden, Germany) according to the user's
protocol. The extent of TRPV6 downregulation by siRNA was analyzed
by real time PCR and Western blot. The maximal suppression of
TRPV6 protein production (approximately 70%) was observed 48 h
after siRNA transfection.
2.4. Calcium imaging
Fura-2 ﬂuorescence was used to detect very small changes of cyto-
solic free Ca2+ ([Ca2+]i). Two days after nt or TRPV6 siRNA transfection,
INS-1E cells were pre-incubated with culture medium containing 1 μM
fura-2/AM for≈30 min at 37 °C. Thereafter, cells were washed with a
Ringer-like solution containing (mM): 120 NaCl, 6 CsCl, 1 MgCl2, 10
glucose, and 10 HEPES acid and 1.5 CaCl2 (pH 7.4), to remove any cell
debris or dead cells. Washed coverslips were mounted in a chamber
containing the Ringer-like solution on the stage of an inverted micro-
scope (Olympus BW50WI, Olympus Europa Holding GmbH, Hamburg,
and Germany) and equilibrated to room temperature (≈22 °C). A digi-
tal imaging system (TILL Photonics, Munich, Germany) was used to
monitor changes in [Ca2+]i based on fura-2ﬂuorescence. Fura-2ﬂuores-
cence was alternately excited at 340 and 380 nmwavelength and emis-
sion was detected every 500 ms at 510 nm. The detection ﬁeld
contained a cluster of fura-2-loaded cells. The ﬂuorescence ratio
(f340 nm/f380 nm) corresponds to changes in [Ca2+]i, which was calculat-
ed according to Grynkiewicz et al. (1985) [22]. For calibration of free
[Ca2+]i, the ﬂuorescence level in the presence of EGTA (2 mM) (Rmin)
or calcium (1.5 mM) (Rmax) was measured. For functional detection of
TRPV6, a similar protocol was used as described in the literature [23].
In brief, measurements of the basal levels of [Ca2+]i were obtained
during the ﬁrst 3 min, followed by an isoosmotic replacement with
Ca2+-free Ringer-like solution (2 mM EGTA). Three minutes later,1.5 mM Ca2+ was added to increase [Ca2+]i. The reversibility of Ca2+
changes is an indicator of cell viability and functional relevance of the
Ca2+ sensing TRPV6 channel [23–26].
TIDA-software was used for data acquisition and evaluation (HEKA,
Lamprecht, Germany). Results are shown as mean traces of [Ca2+]i
(nM) ± SEM with n values indicating the number of experiments per
data point. The measurements lasted 8 min.
2.5. Detection of cell proliferation
INS-1E cells proliferation was evaluated using a Cell Proliferation
ELISA BrdU colorimetric kit (Roche Diagnostics, Penzberg, Germany).
Cells were seeded in 96-well plates and transfected either with 30 nM
nt or TRPV6 siRNA and subsequently cultured in a standard growing
medium. After 24, 48 and 72 h BrdU solution (10 μM) was added and
cells were incubated for an additional 2 h. The incorporation of BrdU
into the DNA was quantiﬁed according to the manufacturer's protocol.
2.6. Detection of cell viability by MTT assay
INS-1E cells were seeded in 96-well plate and transfected either
with nt or TRPV6 siRNA and cultured for 48 h. Thereafter, MTT solution
(0.5 mg/ml) was added and cells were incubated for 30 min. Formed
formazan crystals were then dissolved in 100 μl DMSO and optical den-
sity at 570 nm and 650 nm (reference wave length) was measured as
previously described [27].
2.7. Cell cycle analysis by PI staining
Propidium iodide (PI) staining was performed as previously report-
ed [28] with several modiﬁcations. In brief, 1.5 × 106 INS-1E cells were
transfected either with nt or TRPV6 siRNA and cultured in growingme-
dium for 48 h. Then cells were trypsinized and centrifuged (600 ×g,
5 min). Cell-reach pellet was then resuspended in 900 μl of PBS and
mixed with ethanol (70%). This mixture was then incubated overnight
at −20 °C. Thereafter, cells were centrifuged (600 ×g, 5 min) and
washed with 1 ml of PBS, and centrifuged again (600 ×g, 5 min). The
pellet was resuspended in 500 μl of staining buffer containing PI (20
μg/ml) and RNAse A (20 μg/ml) and incubated at 37 °C for 20 min. At
least 1 × 104 cells were measured by FACS Calibur (BD Biosciences,
Heidelberg, Germany) using a FL2 channel. Apoptotic and proliferating
cells were counted by BD CellQuest Pro™ Software.
2.8. NFAT activity
NFAT reporter assay (Qiagen) was used. In brief, cells were seeded
into black 96 wells plates and cotransfected with nt or TRPV6 siRNA
(each at the concentration of 30 nM) and a mixture of inducible
NFAT-responsive ﬁreﬂy luciferase construct and constructively express-
ing Renilla luciferase construct (40:1) using Attractene Reagent
(Qiagen) according to manufacturer's protocol. After 48 h cells were
lysed and luciferase assays were performed using a dual-luciferase re-
porter assay system (Promega, Witchburg, WI, USA). NFAT-responsive
ﬁreﬂy luciferase activity was normalized to the Renilla luciferase activity.
2.9. Calcineurin activity
INS-1E cells were plated in a Petri dish and immediately transfected
either with 30 nMnt or TRPV6 siRNA using HiPerfect. Calcineurin activ-
ity was assessed after 48 h by Calcineurin Cellular Activity Assay Kit
(Enzo Life Sciences, Farmingdale, NY, USA).
2.10. Western blot
Protein isolation andWestern blot detection of TRPV6 aswell as ERK1/
2 phosphorylation were carried out as recently described [29]. Blocking
Fig. 1. TRPV6mRNA expression and protein production in INS-1E cells and rat pancreatic islets. A, real time PCR detection of TRPV6mRNA expression in rat duodenum (positive control),
rat pancreatic islets and INS-1E cells. B, Western blot detection of TRPV6 in rat pancreatic islets and INS-1E cells. C–E, immunoﬂuorescence detection of TRPV6 in INS-1E cells (C: nuclei
stained with DAPI, D: TRPV6 positivity, E: merged). F–I, immunoﬂuorescence detection of TRPV6 in rat pancreatic islets (F: insulin positive cells, G: TRPV6 positive cells, H: nuclei stained
with DAPI, I:merged). Note TRPV6 positivity in beta cells. J, TRPV6mRNA expression in INS-1E cells transfectedwith nt (white bars) or TRPV6 siRNA (gray bars). K,Western blot detection
of TRPV6protein in INS-1E cells transfectedwith nt or TRPV6 siRNA and quantiﬁcation of TRPV6 protein (normalized to beta-actin) in cells transfectedwith nt (white bars) or TRPV6 siRNA
(gray bars). Results are the mean ± SEM, obtained from at least three replicates.
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Fig. 1 (continued).
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to detect the speciﬁc and non-speciﬁc signals. Signals were visualized
using ChemiDoc MP Imaging System (BioRad, Hercules, CA, USA).
2.11. Immunoﬂuorescence detection of TRPV6
INS-1E cells were cultured in 4 chamber tissue culture slides for 24 h.
Thereafter, cells were washed with PBS and ﬁxed in 4% paraformalde-
hyde in PBS for 10 min. Fixed cells were washed three times with ice
cold PBS and permeabilized by incubating in PBS containing 0.1% Triton
X-100 for 10min. After three 5minwashes in PBS, unspeciﬁc binding of
antibodieswas blocked by incubatingwith blocking solution containing
0.2% gelatine and 15mMglycine for 1 h at RT. Next, cellswere incubated
overnight at 4 °C with anti TRPV6 antibody (dilution 1:250 in blocking
solution). To conﬁrm the speciﬁcity of the primary antibody blocking
TRPV6 peptide was used at the ratio of 3 μg per 1 ml of primary anti-
body. After incubation, cells were washed three times in PBS, each
time for 5 min. Thereafter, cells were incubated with the secondary an-
tibody (dilution 1:500 in blocking solution) for 1 h at RT in the darkness.
Next, cells were washed with PBS (3 × 5 min.). To stain nuclei, cells
were incubated with DAPI (1 μg/ml in PBS) for 1 min. Then, cells were
washed in PBS and cover glass was mounted on culture slides using
Fluoromount G (SouthernBiotech, Birmingham, AL, USA). Cells were
photographed at 400× magniﬁcation using a Zeiss Axiovert 510 Meta
Confocal Laser Scanning Microscope Fluorescence (Carl Zeiss,
Oberkochen, Germany). Immunoﬂuorescence detection of TRPV6 in
pancreatic isletswas performed onparafﬁn-embedded tissue. The slides
(6 μm)were baked in laboratory oven at 58 °C for 45min. Next, the sec-
tions were deparafﬁnized in xylene and rehydrated through a graded
series of ethanol (96%, 85%, 80%, 70%, 50%, 30%). Then, slides were
placed in a microwave oven to unmasked antigenic sites by pre-
treatment for 3 × 5 min in 0.01 M citrate buffer (pH 6.0). The nextstepswere the same as for INS-1E cells except incubationswith primary
and secondary antibodies with or without the blocking peptide (slides
were co-incubated with anti-TRPV6 diluted 1:200 and anti-insulin
antibody diluted 1:500 and then with secondary Cy3 and Alexa Fluor®
488 conjugated antibodies diluted 1:500).
2.12. Real time PCR
RNAwas isolated using Tripure Reagent (RocheDiagnostics) accord-
ing to themanufacturer's instruction. cDNAwas generated using 1 μg of
RNAusing Transcriptor First Strand cDNA Synthesis Kit (RocheDiagnos-
tics). Real-time PCR was prepared using SYBR Green Master Mix with
speciﬁc primers on QuantStudio 12 K Flex™ Real-Time system (Life
Technologies, Grand Island, NY, USA). Gene expression was evaluated
by Delta Delta CT (ΔΔCT) method, using GAPDH as a reference gene.
Sequences of gene-speciﬁc primers are given in Supplementary Table 1.
2.13. Insulin secretion assay
INS-1E cellswere seeded in 24-well plates (1× 105 cell perwell) and
transfected either with 30 nM nt or TRPV6 siRNA. After 48 h cells were
preincubated in glucose-free KRHB containing inmM: 136 NaCl, 4.7 KCl,
1 CaCl2, 1.2 MgSO4, 1.2 KH2PO2, 2 NaHCO3, 10 HEPES (pH 7.4) for 1 h.
Thereafter, cells were washed in glucose-free KRHB and incubated
with the same buffer supplemented either with 2.8 or 16.7 mM glucose
for 20 or 60 min. The concentration of released insulin (normalized to
intracellular insulin content [30]) was determined using a High Range
Rat Insulin ELISA Kit (DRG Instruments GmbH, Germany, Marburg).
The detection limit of the assay was 1.5 μg/l.
2.14. Statistical analysis
The Student's t-test (parametric two-tailed t-test) was used for statis-
tical signiﬁcance determination. If the normality failed Mann–Whitney
test was used. p-values b0.05 (*), p b 0.01 (**) were considered signiﬁ-
cant. Data are means ± SEM and show a representative experiments
performed in triplicates at least.
3. Results
3.1. TRPV6 gene and protein expression in INS-1E cells and rat pancreatic
islets
TRPV6mRNA expressionwas detected in INS-1E cells, rat pancreatic
islets aswell as in rat duodenum (positive control [31]) (Fig. 1A). TRPV6
protein detection in INS-1E cells and pancreatic islets by Western blot
technique revealed two signals of approximately 90 and 70 kDa corre-
sponding to glycosylated and non-glycosylated TRPV6 protein [32]
(Fig. 1B). Presence of TRPV6 in INS-1E cells was conﬁrmed by immuno-
ﬂuorescence (Fig. 1C-e). Double immunoﬂuorescence in rat pancreatic
sections revealed that TRPV6 is expressed in beta cells (Fig. 1F–I).
TRPV6 immunoreactivity detected by Western blot and immunoﬂuo-
rescence using a TRPV6 blocking peptide showed that the antibody
was speciﬁc. As shown in Supplementary Fig. 1a, preincubation of
TRPV6 antibody with the blocking peptide, at the ratio of 3 μg per
1 ml of primary antibody, caused a loss of TRPV6 signals, whereas a
non-speciﬁc signal was still detectable in INS-1E cells. Furthermore,
preincubation of pancreatic sections with the immunizing control
peptide completely blocked TRPV6 immunoreactivity, as detected by
immunoﬂuorescence analysis.
To study the consequences of TRPV6 downregulation on INS-1E cells
physiology, we used siRNA. TRPV6 mRNA expression in INS1-1E cells
was downregulated by approximately 65% (Fig. 1J), whereas protein
production was reduced by approximately 70%, as compared to nt
siRNA-transfected cells (Fig. 1K).
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impaired calcium homeostasis
To investigate the contribution of TRPV6 to the intracellular calcium
inﬂux, we recorded the responses of INS-1E cells to rapid changes of
[Ca2+]i from a Ca2+-free to a 1.5 mM Ca2+ containing extracellular
solution. A similar protocol was used by Lehen'kyi et al. for TRPV6Fig. 2. Effects of TRPV6 downregulation on Ca2+signaling in INS-1E cells in a calcium-free
solution and after calcium replenishment. A, fura-2 loaded INS-1E cells at 510 nm ﬂuores-
cence emissionwavelength. B, baseline levelmeasurementswere obtained during theﬁrst
200 s followed by Ca2+ reduction (left arrow) and a Ca2+ increase after adding 1.5 mM
Ca2+ at 380 s. (right arrow). Intracellular Ca2+ increases above the Ca2+ base line (dashed
line) in nt-transfected cells (open circles). A similar Ca2+ response pattern could be ob-
served in TRPV6 siRNA-transfected INS-1E cells, but at signiﬁcant lower levels on which
the Ca2+ recovery at 420 s did not exceed the base line (ﬁlled circles). Changes in cytosolic
free Ca2+ are depicted as the ratio of theﬂuorescence induced by excitationwavelength of
340 and 380 nm and were then calculated in nM by the equation of Grynkiewicz et al.
(1985). C, summary of the experiments with nt and TRPV6 siRNA-transfected INS-1E
cells. Statistical evaluation of [Ca2+]i was performed after 350 (dark gray bars) and
420 s (light gray bars). Results are the mean ± SEM, obtained from at least ten replicates.detection. Notably, there was a signiﬁcant lower basal level of cytosolic
Ca2+ (control) in cells with TRPV6 downregulation (e.g. 112± 7 nMvs.
171 ± 20 nM at 150 s) (Fig. 2B). In a Ca2+-free solution, [Ca2+]i de-
creased from 170 ± 20 nM (150 s) to 33 ± 11 nM (n = 10; p b 0.005;
t = 350 s) in nt siRNA-transfected INS-1E cells (Fig. 2B–C). In the pres-
ence of extracellular Ca2+, [Ca2+]i increased above the baseline (285 ±
51 nM; n= 10; t = 420 s). In cells with downregulated TRPV6, howev-
er, [Ca2+]i decreased from 112± 7 nM (150 s) to 10± 2 nM, only (n=
10; p b 0.001; t = 420 s). After replacement with the Ca2+ solution,
[Ca2+]i was still below the basal level of cytosolic Ca2+ (92 + 10 nM;
n = 10). Thus, changes of [Ca2+]i in Ca2+-free and Ca2+-solution
were signiﬁcantly reduced in TRPV6 siRNA-transfected cells as com-
pared to wild type INS-1E cells (n = 10; p b 0.01 vs nt-transfected
cells; Fig. 2C). In summary, activation of the Ca2+ sensing TRPV6 chan-
nel stimulates Ca2+ inﬂux in INS-1E cells.
3.3. TRPV6 modulates calcineurin/NFAT activity
It was shown before that TRPV6 modulates NFAT activity in LN-CAP
cells [34]. Since NFAT and the calcium-dependent activator calcineurin
can stimulate beta cells growth and increase insulin production [35],
we therefore measured the activities of calcineurin and NFAT in
TRPV6 siRNA-transfected cells. Suppression of TRPV6mRNA expression
resulted in strongly reduced calcineurin and NFAT activities in INS-1E
cells (Fig. 3A and B, p b 0.05).
3.4. TRPV6 affects the expression of pdx-1, Ccnd1–2, Ccdk4, Irs2 and regu-
lates ERK1/2 phosphorylation
Calcineurin/NFAT pathway was implicated in controlling beta cell
growth-controlling genes such us pdx-1, cyclin D1, cyclin D2 (Ccnd1–2),
cyclin-dependent kinase 4 (Ccdk4) and insulin receptor substrate 2
(Irs2) [35–37]. Since decreased TRPV6 protein production led to
reduced activity of calcineurin/NFAT, we next evaluated the conse-
quences of TRPV6 dowregulation on the mRNA expression of the
above listed genes. Reduction of TRPV6 protein production resulted inFig. 3. Effects of TRPV6 downregulation on calcineurin and NFAT activities in INS-1E cells.
Calcineurin (A) and NFAT (B) activities were assessed in cells transfected with nt (white
bars) or TRPV6 siRNA (gray bars) for 48 h. Results are the mean ± SEM, obtained from
seven replicates.
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(p b 0.05), whereas Ccnd1 expression was not affected (Fig. 4A–E).
Calcineurin is able to modulate ERK1/2 phosphorylation [38]. Since
ERK1/2 modulates cell proliferation and insulin gene expression [39,40]
we next evaluated the consequences of TRPV6 reduction on ERK1/2
phosphorylation. We found that the basal level of ERK1/2 phosphoryla-
tion was reduced in TRPV6 siRNA transfected cells as compared to
TRPV6 wild type INS-1E cells (p b 0.05) (Fig. 4F).
3.5. TRPV6 controls INS-1E cell proliferation
Since TRPV6 modulates the expression of beta cell growth-
regulating genes,we asked nextwhether TRPV6 affects INS-1E cells pro-
liferation. Indeed, two and three days after TRPV6 siRNA transfection,
INS-1E cell proliferation was reduced as compared to nt transfected
cells (Fig. 5A; p b 0.01).
Moreover, TRPV6 downregulation led to reduced cell viability
(Fig. 5B, p b 0.01). The promitogenic activity of TRPV6 in INS-1E cellsFig. 4. Expression of selected genesmodulating beta cell proliferation in INS-1E cells transfected
(B), cyclin D2 (C) and cyclin-dependent kinase 4 (D) insulin receptor substrate 2 (E) were norm
nt or TRPV6 siRNA. ERK1/2 phosphorylation was normalized to total ERK1/2 as loading contr
replicates (ERK1/2 phosphorylation).was conﬁrmed by cell cycle analysis. The number of cells in S-phase de-
creased in cells with downregulated TRPV6 protein levels (p b 0.05),
whereas the number of death cells increased (Fig. 5C, p b 0.05). Overall,
these data reveal the importance of TRPV6 in controlling INS-1E cell
proliferation.3.6. TRPV6 affects insulin expression but not insulin secretion
As shown in our current study TRPV6 regulates calcineurin/NFAT ac-
tivities (Fig. 3A–B). Calcineurin/NFAT signaling is involved in modula-
tion of insulin mRNA expression [36]. We therefore examined
whether TRPV6 modulates insulin mRNA expression and secretion in
INS-1E cells. Downregulation of TRPV6 protein productionwas associat-
ed with a decrease of InsmRNA expression (p b 0.05)mRNA by approx-
imately 17% (Fig. 6A). However, no effects on insulin secretion, neither
at low (2.8 mM) nor high (16.7 mM) glucose concentration (p N 0.05,
Fig. 6B–C) were detected. These data suggest that TRPV6 plays a rolewith nt (white bars) or TRPV6 siRNA (gray bars) for 48 h. Expressions ofpdx1 (A), cyclinD1
alized to Gapdh as housekeeping gene. F, ERK1/2 phosphorylation in cells transfectedwith
ol. Results are the mean ± SEM, obtained from at least ﬁve (mRNA expression) or three
Fig. 5. Effects of TRPV6downregulation on INS-1E cell proliferation, viability and cell cycle.
A, INS-1E cell proliferation was assessed 1, 2 and 3 days after transfection with nt (open
circles) or TRPV6 siRNA (ﬁlled circles). B, cell viability was assessed 2 days after transfec-
tion with nt (white bars) or TRPV6 siRNA (gray bars). C, cell cycle was analyzed 3 days
after transfection with nt (white bars) or TRPV6 siRNA (gray bars). Results are the
mean ± SEM, obtained from at least 6 (cell proliferation and viability) or three replicates
(cell cycle analysis).
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secretion.
4. Discussion
In the present study, we identify TRPV6 expression and protein pro-
duction in INS-1E cells and rat pancreatic beta cells. TRPV6 mRNA has
been already detected in human beta cells [15]. However, the function
of this channel in beta cells is still unknown. In the current study, we
show that the Ca2+ sensing TRPV6 channel regulates intracellular calci-
um as well as INS-1E cell proliferation and insulin mRNA expression.
Previous studies in prostate cancer demonstrated that TRPV6 trig-
gers cell growth, possibly via transcriptional factor NFAT [34]. The link
between TRPV6 and NFAT activity was also reported in the human
colon carcinoma Caco-2 cells [41]. It is known that NFAT interacts
with calcium-signaling. Calcium activates a protein phosphatase
calcineurin. Activated calcineurin can dephosphorylate NFAT which
then translocates into the nucleus to initiate expression of various target
genes [42]. NFATs are also expressed in pancreatic beta cells [35]. Ourstudy demonstrates a possible link between TRPV6, Ca2+ and calcine-
urin/NFAT pathway in our experimental beta cell model INS-1E cells.
Notably, there is evidence from previous studies showing that both,
NFAT as well as calcineurin can affect various functions of pancreatic
beta cells such as cell proliferation and viability [35,37].Mechanisms en-
compass modulation of cell cycle as well as survival-controlling genes
such as pdx1, cyclins and cyclin-dependent kinases [35,36]. Additional-
ly, calcineurin can modulate beta cell survival via Irs2 [37] and ERK1/2-
pathway [38]. In agreement with these reports, we found that TRPV6
downregulation led to a reduction of calcineurin/NFAT activity which
was accompanied by the reduction of Pdx1, Ccnd2, Cdk4 and Irs2
mRNA expression. In contrast, Ccnd1 expression was not affected by
TRPV6 downregulation. Furthermore, suppression of calcineurin/NFAT
activity following TRPV6 downregulation was associated with reduced
ERK1/2 phosphorylation. Since all above listed genes as well as ERK1/2
signaling are crucially important for the growth of pancreatic beta
cells [43,44], we assessed the role of TRPV6 in controlling INS-1E cells
proliferation. As a result, we found that TRPV6 stimulates cell prolifera-
tion. This observation is not surprising in the light of data showing the
importance of ions and calcium channels in modulating pancreatic
beta cell growth [2]. Importantly, the loss of TRPV6 protein production
caused a maximal 30% decrease in INS-1E cell proliferation despite the
presence of 10% serum. Thus, it is rationale to speculate that the role
of TRPV6 in modulating cell growth may be physiologically relevant.
Noteworthy, highly efﬁcient stimuli of INS-1 cell proliferation such as
GLP-1 or hepatocyte growth factor can increase beta cell replication by
approximately 80–100% [45,46]. However, these experiments were
conducted in a serum-free condition, which is of questionable physio-
logical signiﬁcance.
The relevance of TRPV6 in controlling cell proliferation is in agree-
ment with the notion that TRPV6 augments HEK-293 cell growth [47]
and is highly expressed in rapidly proliferating cells e.g. prostate [13]
or breast cancers [48]. In LNCaP prostate cancer cells, TRPV6 stimulates
cell proliferation and survival [34], which was inferred from experi-
ments using TRPV6 siRNA. Notably, the extent of suppression of LNCaP
cell proliferation by TRPV6 siRNA (approximately 25% three days after
siRNA transfection) [23,34] was highly comparable to that detected
in our experiments using INS-1E cells (30% percent vs. nt siRNA-
transfected cells after three days).
Several studies reported that NFAT/calcineurin and ERK1/2 path-
ways are required for insulin mRNA expression [40,49]. Concordantly,
we found that TRPV6 siRNA-transfected cells had lower Ins mRNA
expression. Overall, these results indicate that TRPV6 stimulates
INS-1E cell proliferation as well as insulin mRNA expression.
In contrast to the trophic activity of TRPV6 in INS-1E cells, we found
that the downregulation of TRPV6 failed to affect insulin secretion. This
ﬁnding may suggest that other Ca2+ permeable channels (e.g. L-type
voltage operated channels) are sufﬁcient formaintaining normal insulin
exocytosis in response to glucose. In this context it is worth to notice
that in our earlier workwe did not observe any changes in insulin secre-
tion in INS-1E cell with downregulated TRPV4 protein production [6].
Noteworthy, likewise TRPV6, TRPV4 is also active in the optimal
temperature of living organism [50]. However, it is possible that
TRPV6 deﬁciency in INS-1E cells was compensated by increased expres-
sion of other calcium-permeable channels which could result in normal
insulin secretion. Overall, these results suggested that TRPV6 is rather
not required for insulin secretion in INS-1E cells. In the literature, it is
known that other TRPs such as TRPV2 and TRPM4 are relevant for the
regulation of insulin secretion [7,19].
An important limitation in our studies is the use of TRPV6 siRNA
technique as the only molecular tool for TRPV6 detection. Reason is
the lack of speciﬁc pharmacological antagonists for TRPV6. However,
this limitation is also a hallmark of earlier studies [34,51]. Nevertheless,
it is worth to notice that TRPV6 can be activated by vitamin D as well as
estrogen [23,52,53]. These TRPV6 modulators were shown to improve
human and rodent pancreatic beta cells endocrine and metabolic
Fig. 7. Proposed model of TRPV6 functions in INS-1E cells. Ca2+ entry through TRPV6 ac-
tivates calcineurin/NFAT signaling. Dephosphorylated NFAT is translocated to the nucleus
where regulates expression of genes which are involved in cell proliferation.
Fig. 6.Effects of TRPV6downregulation in TRPV6 siRNA-transfected cells (gray bars) on in-
sulin expression and secretion. A, insulin expression normalized toGapdh as housekeeping
gene. B–C, Consequences of TRPV6 downregulation in INS-1E cells on insulin secretion
detected at 2.8 (white bars) or 16.7 mM glucose (gray bars) after 20 (B) or 60 min
(C). Results are the mean ± SEM, obtained from six replicates.
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of TRPV6-independent pathways [56,57], the results obtained with
these both modulators of pancreatic beta cells need to be interpreted
cautiously. Furthermore our study was performed in experimental
INS-1E beta cell model and not in isolated primary single pancreatic
beta cells. Despite detection of TRPV6 in insulin-immunoreactive cells
in rat pancreatic islets, we cannot exclude that the expression levels of
TRPV6 may be differ between INS-1E cells, as compared to primary
beta cells. Also the function of TRPV6 may differ in primary beta cells
as compared to INS-1E cell line. However, INS-1E is a well-established
cell line to study the intracellular beta cell signaling, which was the
major aspect of our in vitro study. Further studies of TRPV6 function in
primary beta cells or in animals with genetically engineered TRPV6
will be therefore required to verify the relevance of our original ﬁndings
reported in the experimental INS-1E cell line.In conclusion, TRPV6 is expressed in rat INS-1E cell line as well as in
beta cells in pancreatic islets. TRPV6 controls calcium inﬂux. Intracellu-
lar calciummodulates calcineurin/NFAT activity which likelymodulates
genes expression as well as cell proliferation (Fig. 7). TRPV6 fails to
affect insulin secretion. These ﬁndings are compatible with the notion
that TRPV6 has a relevance for the neoplastic growth and transforma-
tion of neuroendocrine cells.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2015.09.012.Transparency document
The Transparency document associated with this article can be found,
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